Page last updated: 2024-10-26

diphenyleneiodonium and Diabetic Neuropathies

diphenyleneiodonium has been researched along with Diabetic Neuropathies in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ji, ZH1
Liu, ZJ1
Liu, ZT1
Zhao, W1
Williams, BA1
Zhang, HF1
Li, L1
Xu, SY1

Other Studies

1 other study available for diphenyleneiodonium and Diabetic Neuropathies

ArticleYear
Diphenyleneiodonium Mitigates Bupivacaine-Induced Sciatic Nerve Damage in a Diabetic Neuropathy Rat Model by Attenuating Oxidative Stress.
    Anesthesia and analgesia, 2017, Volume: 125, Issue:2

    Topics: Anesthetics, Local; Animals; Bupivacaine; Diabetic Neuropathies; Electrophysiology; Enzyme Inhibitor

2017